Lv11
42 积分 2023-04-21 加入
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) – biology, clinical results and future directions
5小时前
待确认
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1天前
已完结
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
12天前
已完结
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
12天前
已完结
Pinellia exosomal vesicles remodulate tumor-associated macrophage polarization via the serine synthesis/JAK/STAT signaling pathway to inhibit lung cancer growth
1个月前
已完结
A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers
1个月前
已完结
IL-15: from discovery to FDA approval
2个月前
已完结
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy
2个月前
已完结
Interleukin 2-Based Cancer Immunotherapies: The Discovery of Next-Generation Antibody-Cytokine Bispecific Antibody Drug
2个月前
已完结
皖公网安备34019202002308
